ATORIS

This brand name is authorized in Albania, Croatia, Estonia, Germany, Hong Kong SAR China, Italy, Lithuania, Poland, Romania, Singapore, Spain.

Active ingredients

The drug ATORIS contains one active pharmaceutical ingredient (API):

1	Atorvastatin UNII 48A5M73Z4Q - ATORVASTATIN CALCIUM TRIHYDRATE
	Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.
	Read more about Atorvastatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA05	Atorvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	356/73, 357/73
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	09633681, 09633698, 09633706, 09633712, 09633729, 09633735, 09633741, 09633758, 09633764, 09633770, 09633787, 09633793, 09633801, 09633818, 09633824, 09633853
EE	Ravimiamet	1138047, 1138058, 1220993, 1221006, 1221017, 1479180, 1479191, 1479203, 1479214, 1479225, 1479236, 1479247, 1479258, 1479269
ES	Centro de información online de medicamentos de la AEMPS	71718, 74684, 74685
HK	Department of Health Drug Office	59468, 59869
HR	Agencija za lijekove i medicinske proizvode	HR-H-099895884, HR-H-544834083, HR-H-721076914, HR-H-807617397, HR-H-810347527, HR-H-902872961
IT	Agenzia del Farmaco	040561072, 040561211, 040561351, 040561779
LT	Valstybinė vaistų kontrolės tarnyba	1003981, 1003982, 1021400, 1054094, 1054095, 1054096, 1060326, 1060327, 1060328, 1060329, 1060330, 1060331, 1060332, 1060333, 1060334, 1060335, 1060336, 1060337, 1060338, 1060339, 1060340, 1060341, 1060342, 1060343, 1060344, 1060345, 1060346, 1060347, 1060348, 1060349, 1060350, 1060351, 1060352, 1060353, 1060354, 1060355, 1060356, 1060357, 1060358, 1060359, 1060360, 1060361, 1060362, 1060363, 1060364, 1088026, 1088027, 1089446, 1091305
PL	Rejestru Produktów Leczniczych	100113400, 100113416, 100164721, 100251621, 100251638, 100251644
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W54696001, W54696002, W54696003, W54696004, W54696005, W54696006, W54696007, W54696008, W54696009, W54696010, W54696011, W54696012, W54696013, W54696014, W54697001, W54697002, W54697003, W54697004, W54697005, W54697006, W54697007, W54697008, W54697009, W54697010, W54697011, W54697012, W54697013, W54697014, W54698001, W54698002, W54698003, W54698004, W54698005, W54698006, W54698007, W54698008, W54698009, W54698010, W54698011, W54698012, W54698013, W54698014, W57506001, W57506002, W57506003, W57506004, W57506005, W57506006, W57506007, W57506008, W57506009, W57506010, W57506011, W57506012, W57506013, W57506014, W57507001, W57507002, W57507003, W57507004, W57507005, W57507006, W57507007, W57507008, W57507009, W57507010, W57507011, W57507012, W57507013, W57507014, W57508001, W57508002, W57508003, W57508004, W57508005, W57508006, W57508007, W57508008, W57508009, W57508010, W57508011, W57508012, W57508013, W57508014
SG	Health Sciences Authority	14216P, 14217P